Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 6
Submit an article Journal homepage
535
Views
9
CrossRef citations to date
0
Altmetric
Neurology

Secondary progressive multiple sclerosis: a systematic review of costs and health state utilities

Jeremy Chatawaya Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK;b National Institute for Health Research, Biomedical Research Centre, University College London Hospitals, London, UKORCID Iconhttps://orcid.org/0000-0001-7286-6901
ORCID Icon,
Niamh Murphyc Novartis Pharma AG, Basel, Switzerland
,
Vivek Khuranad Patient Access Solutions, Novartis Corporation (Malaysia) Sdn. Bhd, Petaling Jaya, MalaysiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6571-0263
ORCID Icon,
Helen Schofielde Oxford PharmaGenesis, Oxford, UK
,
John Findlaye Oxford PharmaGenesis, Oxford, UK
&
Nicholas Adlardc Novartis Pharma AG, Basel, SwitzerlandORCID Iconhttps://orcid.org/0000-0001-6912-1685
ORCID Icon
Pages 995-1004 | Received 14 Dec 2020, Accepted 14 Mar 2021, Published online: 06 Apr 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dirk Schriefer, Rocco Haase, Nils-Henning Ness & Tjalf Ziemssen. (2022) Cost of illness in multiple sclerosis by disease characteristics – A review of reviews. Expert Review of Pharmacoeconomics & Outcomes Research 22:2, pages 177-195.
Read now

Articles from other publishers (8)

Marien Gonzalez-Lorenzo, Ben Ridley, Silvia Minozzi, Cinzia Del Giovane, Guy Peryer, Thomas Piggott, Matteo Foschi, Graziella Filippini, Irene Tramacere, Elisa Baldin & Francesco Nonino. (2024) Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis. Cochrane Database of Systematic Reviews 2024:1.
Crossref
Crystal Watson, Dhanalakshmi Thirumalai, Arie Barlev, Eddie Jones, Sasha Bogdanovich & Kiren Kresa-Reahl. (2023) Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021. Neurology and Therapy 12:6, pages 1961-1979.
Crossref
Tham Thi Nguyen, Huong Van Nguyen, Hai Minh Vu, Ryan G. Chiu, Quang Nhat Nguyen, Thao Thi Phuong Nguyen, Long Hoang Nguyen, Anh Kim Dang, Khanh Nam Do, Tu Huu Nguyen, Vu Nguyen, Anh Toan Ngo, Tung Hoang Tran, Carl A. Latkin, Cyrus S. H. Ho & Roger C. M. Ho. (2023) Factors correlated with neuropathic pain among industrial workers in Vietnam: a multi-site cross-sectional study. Frontiers in Public Health 11.
Crossref
Tjalf Ziemssen, Virender BhanJeremy ChatawayTanuja ChitnisBruce Anthony Campbell Cree, Eva Kubala HavrdovaLudwig KapposPierre LabaugeAaron MillerJin NakaharaCelia Oreja-Guevara, Jacqueline PalaceBarry SingerMaria TrojanoAshwini PatilBenedict RauserThomas Hach. (2023) Secondary Progressive Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation 10:1.
Crossref
Dyfrig A. Hughes, Siobhan Bourke, Angela Jones, Rikesh Bhatt, Saif Huda, Kerry Mutch & Anu Jacob. (2022) Health utilities and costs for neuromyelitis optica spectrum disorder. Orphanet Journal of Rare Diseases 17:1.
Crossref
Steven Simoens. (2022) Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies. Frontiers in Neurology 13.
Crossref
Vivien Li, Baptiste Leurent, Frederik Barkhof, Marie BraisherFay CaffertyOlga Ciccarelli, Arman Eshaghi, Emma GrayJennifer M. NicholasMahesh Parmar, Guy Peryer, Jenny RobertsonNigel StallardJames Wason & Jeremy Chataway. (2022) Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis. Neurology 98:18, pages 754-764.
Crossref
Martin Elišák. (2022) Management of secondary-progressive multiple sclerosis. Neurologie pro praxi 23:1, pages 57-62.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.